Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: The effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 33-44

  Ferguson, Susan M ^a   Norton, Camille S ^b   Watson, Stanley J ^a,b   Akil, Huda ^a,b   Robinson, Terry E ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dopamine; Glutamate; Immediate early genes; In situ hybridization; Rat; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DIZOCILPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ECOPIPAM; L 741262; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; PREPRODYNORPHIN; PREPROTACHYKININ; PSYCHOSTIMULANT AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; IMMEDIATE EARLY GENE; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; PUTAMEN; RAT; STRESS;

AMPHETAMINE; ANIMALS; CAUDATE NUCLEUS; CELL COUNT; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; ENVIRONMENT; EXCITATORY AMINO ACID ANTAGONISTS; IN SITU HYBRIDIZATION; MALE; NEURONS; PHENOTYPE; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SPATIAL BEHAVIOR; TACHYKININS;

ANIMALIA;

EID: 0037632954     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01815.x     Document Type: Article

References (58)

1. Badiani A., Camp D. M. and Robinson T. E. (1997) Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J. Pharmacol. Exp. Ther. 282, 787-794.
2. Badiani A., Oates M. M., Day H. E., Watson S. J., Akil H. and Robinson T. E. (1998) Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci. 18, 10579-10593.
3. Badiani A., Oates M. M., Day H. E., Watson S. J., Akil H. and Robinson T. E. (1999) Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav. Brain Res. 103, 203-209.
4. Berretta S., Robertson H. A. and Graybiel A. M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68, 767-777.
5. Berretta S., Robertson H. A. and Graybiel A. M. (1993) Neurochemically specialized projection neurons of the striatum respond differentially to psychomotor stimulants. Prog. Brain Res. 99, 201-205.
6. Berretta S., Parthasarathy H. B. and Graybiel A. M. (1997) Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17, 4752-4763.
7. Berretta S., Sachs Z. and Graybiel A. M. (1999) Cortically driven Fos induction in the striatum is amplified by local dopamine D2-class receptor blockade. Eur J. Neurosci. 11, 4309-4319.
8. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
9. Cenci M. A. and Bjorklund A. (1993) Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Neurosci. 5, 1062-1070.
10. Cenci M. A., Kalen P., Mandel R. J., Wictorin K. and Bjorklund A. (1992) Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience 46, 943-957.
11. Cole R. L., Konradi C., Douglass J. and Hyman S. E. (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823.
12. Curran E. J. and Watson S. J. Jr (1995) Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361, 57-76.
13. Drago J., Gerfen C. R., Westphal H. and Steiner H. (1996) D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience 74, 813-823.
14. Dragunow M., Logan B. and Laverty R. (1991) 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur. J. Pharmacol. 206, 255-258.
15. Duffy R. A., Hunt M. A., Wamsley J. K. and McQuade R. D. (2000) In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists. J. Chem. Neuroanat. 19, 41-46.
16. Falk J. L. and Feingold D. A. (1987) Environmental and cultural factors in the behavioral actions of drugs, in Meltzer, H. Y., ed. Psychopharmacology: The Third Generation of Progress, pp. 1503-1510. Raven Press, New York.
17. Fenu S., Carta A. and Morelli M. (1995) Intranigral injections of glutamate antagonists modulate dopamine D1-mediated turning behavior and striatal c-fos expression. J. Neural Transm. Suppl. 45, 75-81.
18. Fu L. and Beckstead R. M. (1992) Cortical stimulation induces fos expression in striatal neurons. Neuroscience 46, 329-334.
19. Gardier A. M., Moratalla R., Cuellar B., Sacerdote M., Guibert B., Lebrec H. and Graybiel A. M. (2000) Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. J. Neurochem. 74, 1363-1373.
20. Gerfen C. R., Miyachi S., Paletzki R. and Brown P. (2002) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054.
21. Graybiel A. M., Moratalla R. and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA 87, 6912-6916.
22. Harlan R. E. and Garcia M. M. (1998) Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16, 221-267.
23. Hyman S. E. and Malenka R. C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703.
24. Jaber M., Cador M., Dumartin B., Normand E., Stinus L. and Bloch B. (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65, 1041-1050.
25. Johansson B., Lindstrom K. and Fredholm B. B. (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59, 837-849.
26. Kawaguchi Y., Wilson C. J., Augood S. J. and Emson P. C. (1995) Striatal intemeurones: chemical, physiological and morphological characterization. Trends Neurosci. 18, 527-535.
27. Keefe K. A. and Gerfen C. R. (1995) D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66, 903-913.
28. Keefe K. A. and Gerfen C. R. (1996) D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. Comp. Neurol. 367, 165-176.
29. Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 5623-5634.
30. Konradi C., Leveque J. C. and Hyman S. E. (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16, 4231-4239.
31. LaHoste G. J., Henry B. L. and Marshall J. F. (2000) Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J. Neurosci. 20, 6666-6671.
32. Li B. H. and Rowland N. E. (1993) Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31, 43-48.
33. Lindefors N. and Ungerstedt U. (1990) Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci. Lett. 115, 248-252.
34. Liste I., Rozas G., Guerra M. J. and Labandeira-Garcia J. L. (1995) Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res. 700, 1-12.
35. McGinty J. F. and Wang J. Q. (1998) Drugs of abuse and striatal gene expression. Adv. Pharmacol. 42, 1017-1019.
36. McPherson R. J. and Marshall J. F. (2000) Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. Synapse 36, 194-204.
37. Moratalla R., Xu M., Tonegawa S. and Graybiel A. M. (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl Acad. Sci. USA 93, 14928-14933.
38. Nestler E. J., Hope B. T. and Widnell K. L. (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11, 995-1006.
39. Parthasarathy H. B. and Graybiel A. M. (1997) Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17, 2477-2491.
40. Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego.
41. Quinlan E. M., Philpot B. D., Huganir R. L. and Bear M. F. (1999) Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo. Nat. Neurosci. 2, 352-357.
42. Robinson T. E., Browman K. E., Crombag H. S. and Badiani A. (1998) Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci. Biobehav. Rev. 22, 347-354.
43. Ruskin D. N. and Marshall J. F. (1994) Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 18, 233-240.
44. Sgambato V., Abo V., Rogard M., Besson M. J. and Deniau J. M. (1997) Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81, 93-112.
45. Sgambato V., Pages C., Rogard M., Besson M. J. and Caboche J. (1998a) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814-8825.
46. Sgambato V., Vanhoutte P., Pages C., Rogard M., Hipskind R., Besson M. J. and Caboche J. (1998b) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neurosci. 18, 214-226.
47. Snyder-Keller A. M. (1991) Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113, 155-165.
48. Standaert D. G., Friberg I. K., Landwehrmeyer G. B., Young A. B. and Penney J. B. Jr (1999) Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and intemeurons in the striatum of the rat. Brain Res. Mol. Brain Res. 64, 11-23.
49. Tang Y. P., Shimizu E., Dube G. R., Rampon C., Kerchner G. A., Zhuo M., Liu G. and Tsien J. Z. (1999) Genetic enhancement of learning and memory in mice. Nature 401, 63-69.
50. Uslaner J., Badiani A., Day H. E., Watson S. J., Akil H. and Robinson T. E. (2001a) Environmental context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res. 920, 106-116.
51. Uslaner J., Badiani A., Norton C. S., Day H. E., Watson S. J., Akil H. and Robinson T. E. (2001b) Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur. J. Neurosci. 13, 1977-1983.
52. Uslaner J. M., Norton C. S., Watson S. J., Akil H. and Robinson T. E. (2003) Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotype. J. Neurochem. 85, 105-114.
53. Vargo J. M. and Marshall J. F. (1995) Time-dependent changes in dopamine agonist-induced striatal Fos immunoreactivity are related to sensory neglect and its recovery after unilateral prefrontal cortex injury. Synapse 20, 305-315.
54. Wang J. Q. and McGinty J. F. (1997) Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 748, 62-70.
55. Wang J. Q., Daunais J. B. and McGinty J. F. (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18, 343-353.
56. West A. R. and Grace A. A. (2002) Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J. Neurosci. 22, 294-304.
57. Young S. T., Porrino L. J. and Iadarola M. J. (1991) Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl Acad. Sci. USA 88, 1291-1295.
58. Yung K. K., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J. and Levey A. I. (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65, 709-730.